TY - JOUR T1 - Herpes Zoster Infection In Childhood: Prospective Evaluation of 21 Cases TT - Çocukluk Çağında Herpes Zoster Enfeksiyonu:21 Olgunun Prospektif Değerlendirilmesi AU - An, İsa AU - Öztürk, Murat AU - Aksoy, Mustafa PY - 2019 DA - March Y2 - 2019 JF - Harran Üniversitesi Tıp Fakültesi Dergisi PB - Harran Üniversitesi WT - DergiPark SN - 1304-9623 SP - 33 EP - 36 VL - 16 IS - 1 LA - en AB - Background:Herpes zoster (HZ) is a disease caused by the reactivation of varicella zostervirus, which remains latent in the dorsal root ganglion. HZ is a rarely seendisease in childhood. HZ is more common in pediatric patients withimmunosuppressive drug use, immunodeficiency and malignancy. This studyexamined the clinical characteristics of children with HZ.Methods:Twenty one pediatric patients admitted to our dermatology clinic betweenJanuary 2017 and July 2018 and diagnosed with HZ were evaluated prospectively.Patients were evaluated in term of age, sex, affected dermatome, history ofprevious varicella, varicella vaccine, accompanying disease, complicationdevelopment and treatment. Results:Twelve (57.1%) of the 21 pediatric patients with HZ were male and 9 (42.9%)were female. The mean age of the patients was 10.1 years (6-16 years). Fourteen (66.6%) patients had thoracicdermatome involvement, 5 (23.8%) patients had cervical involvement, and 2(9.5%) patients had lumbar dermatome involvement. Two patients were receiving systemicchemotherapy for ALL. In our study 71.4% of patients had a history of varicellaand there was no history of varicella vaccine in any of the patients. None of thepatients developed dissemination and no major complication was observed.Conclusion:In conclusion, while HZ is also seen in healthy children, children who areimmunosuppressed are more affected.Similar to adult disease, thoracic dermatomal involvement is the mostcommon. Complications such as postherpetic neuralgia due to HZ in healthychildren are rarely seen. KW - Childhood KW - Herpes Zoster KW - Varicella zoster virus N2 - Amaç:Herpes zoster(HZ), dorsal kök ganglionunda latentolarak kalan Varicella zoster virüs’ün reaktivasyonu sonucunda gelişen birhastalıktır. HZ çocukluk çağında nadir görülen bir hastalıktır. HZ, çocuklukçağında immünsupresif ilaç kullanımı, immünyetmezlik ve malignite durumlarında daha sık olarakkarşımıza çıkabilir. Bu çalışmada polikliniğimize başvuran HZ tanısı konulançocuk hastaların kliniközellikleri ve eşlik eden hastalıklar incelendi.Materyalve Metot: Hastanemizderi ve zührevi hastalıkları polikliniğine Ocak 2017- Temmuz 2018 tarihleri arasında başvuranve HZ tanısı konulan 18 yaşından küçük 21 hasta prospektif olarakdeğerlendirildi. Hastalar yaş, cinsiyet, tutulan dermatom, geçirilmiş varisellaöyküsü, varicella aşısı öyküsü, eşlikeden hastalıklar, komplikasyon gelişimi ve tedavi açısından değerlendirildi.Bulgular:HZ tanısı konulan 21 çocuk hastanın 12(%57,1)’si erkek, 9 (%42,9)’ u kızidi. Hastaların yaş ortalaması 10,1 yıl(6-16 yaş) olarak saptandı. On dört(%66,6) hastada torakal dermatom tutulurken, 5 (%23,8) hastada servikalve 2 (%9,5) hastada lomber dermatom tutulumu izlendi. İki hasta ALL tanısınedeniyle sistemik kemoterapi almaktaydı.Hastaların hiçbirinde varisellaaşısı olma öyküsü yoktu. Varisella geçirme öyküsü hastaların15(%71,4)’inde vardı. On altı (%76,1)hastaya sistemik antiviral tedavi verildi. Hastalarımızın hiçbirindedisseminasyon gelişmedi. Hastalarda postherpetik nevralji veya majör birkomplikasyon görülmedi.Sonuç: HZ,immünsupresyonu olan çocuk hastalarda sıklıkla görülmesine rağmensağlıklı çocuklarda da görülebilmektedir. Erişkin hastalarabenzer şekilde en sık torakal dermatomtutulumu görülür. Sağlıklı çocuklarda HZ’ ye bağlı postherpetik nevralji gibikomplikasyonlar nadir olarak görülür. CR - 1.Ozuguz P, Kacar SD, Polat S, et al. Childhood Zona Zoster Infection: 12 Case Reports. Abant Med J 2014;3(3):253-6. CR - 2.Gilde DH, Cohrs RJ, Mahalingam R.Clinical and molecular pathogenesis of varicella virus infection.Viral Immunol 2003;16(3):243-58. CR - 3.Gershon AA: Varicella-Zoster Virus Infections. Pediatr Rev 2008;29(1):5-11. CR - 4.Arvin AM. Varicella-zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol 2001;4(4):442-449. CR - 5.Rahsan M, Evans SE, Sahin S. Herpes zoster infection in childhood: Retrospective study of 15 cases.Turkiye Klinikleri J Dermatol 2005;15(3):121-124 CR - 6.Guven M, Bozkurt EC. Herpes Zoster Infection in Childhood: An Evaluation of 24 Cases.Turkish J Pediatr Dis 2017;4:233-8 CR - 7.Prabhu S, Sripathi H, Gupta S, et al. Chilhood Herpes Zoster: A Clustering of ten Cases. Indian J Dermatol 2009;54(1):62–4. CR - 8.Yalaki Z, Ozturk A, Tasar MA. Herpes Zoster Infections In Healthy Children. J Pediatr Inf 2010;4:96-9. CR - 9.Colgecen E, Kucuk O, Balcı M.Clinical Features of Herpes Zoster Infections in Childhood.Turkderm 2012;46:26-8. CR - 10.Lin YH, Huang LM, Chang IS, et al. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28(5):1217-1220. CR - 11.Guess HA, Broughton DD, Melton LJ III, et al. Epidemiology of herpes zoster in children and adolescents: a populationbased study. Pediatrics 1985;76(4):512– 517. CR - 12.Terada K, Kawano S, Yoshihiro K, et al.Characteristics of herpes zoster in otherwise normal children. Pediatr Infect Dis J 1993;12(11):960– 961. CR - 13.Wehrle PF. Bilateral herpes Zoster in a child following exposure to chicken pox. JAMA 1976; 235:2238. CR - 14.Wurzel CL, Kahan J, Heitler M, et al. Prognosis of herpes zoster in healthy children. Am J Dis Child 1986;140(5):477-478. CR - 15.Petursson G, Helgason S, Gudmundsson S, et al. Herpes zoster in children and adolescents. Pediatr Infect Dis J 1998;17(10):905- 8. CR - 16.Smith CG, Glaser DA. Herpes zoster in childhood: case report and review of literature. Pediatr Dermatol 1996;13(3):226-9. CR - 17. Van Hoek AJ, Melegaro A, Zagheni E, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2011;29(13):2411-20. CR - 18.Kurlan JG, Connelly BL, Lucky AW. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: Four case reports and a review of infantile herpes zoster. Arch Dermatol 2004;140(10):1268-72. CR - 19.Johnson RW, Alvarez-Pasquin MJ, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: A multidisciplinary perspective. Ther Adv Vaccines 2015;3(4):109-20. CR - 20.Morgan R, King D. Shingles: a review of diagnosis and management. Hosp Med 1998; 59(10):770-6. CR - 21.Grote V, Von Kries R, Rosenfeld E, et al. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis 2007;196(10):1455-8. CR - 22.Takayama N, Yamada H, Kaku H, et al. Herpes zoster in immunocompetent and immunocompromised Japanese children. Pediatr Int 2000;42(3):275-9. CR - 23.Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009;84(3):274-80. CR - 24.Katakam BK, Kiran G, Kumar U. A prospective study of herpes zoster in children. Indian J Dermatol 2016;61(5):534-9. CR - 25.Hong SM, Yang YS. A case of optic neuritis complicating herpes zoster ophthalmicus in a child. Korean J Ophthalmol 2010;24(2):126- 30. UR - https://dergipark.org.tr/tr/pub/hutfd/issue//521204 L1 - https://dergipark.org.tr/tr/download/article-file/677003 ER -